Job/Unit: O31303
/KAP1
Date: 31-10-13 11:37:14
Pages: 9
D. Tejedor, F. García-Tellado et al.
FULL PAPER
1 H), 7.50 (d, JH,H = 12.4 Hz, 1 H) ppm. 13C NMR (100 MHz, 3JH,H = 5.8 Hz, 3 H), 3.66 (s, 3 H), 4.02–4.11 (m, 1 H), 5.21 (d,
3
3
CDCl3): δ = 9.3, 27.2, 29.3, 32.9, 50.9, 84.8, 96.5, 115.4, 137.4,
162.9, 168.6 ppm. MS (70 eV): m/z (%) = 198 (0.1) [M]+, 121 (2.5),
97 (11), 81 (12), 71 (15), 55 (100). HRMS: calcd. for C11H18O3
198.1256; found 198.1247.
3JH,H = 12.5 Hz, 1 H), 7.51 (d, JH,H = 12.5 Hz, 1 H) ppm. 13C
NMR (100 MHz, CDCl3): δ = –5.4, 18.3, 20.0, 25.9, 28.4, 32.7,
50.9, 62.6, 79.6, 96.8, 162.1, 168.5 ppm. MS (70 eV): m/z (%) = 245
(5.8) [M – 57]+, 201 (5.9), 160 (12), 159 (100), 143 (10), 89 (27),
75 (33), 69 (53). HRMS: calcd. for C11H21O4Si 245.1209; found
245.1204.
1
Methyl (E)-3-(But-3-en-2-yloxy)acrylate (4o): H NMR (400 MHz,
3
CDCl3): δ = 1.37 (d, JH,H = 6.4 Hz, 3 H), 3.67 (s, 3 H), 4.43–4.51
3
(m, 1 H), 5.20–5.28 (m, 3 H), 5.75–5.85 (m, 1 H), 7.50 (d, JH,H
=
Representative Procedure for the Synthesis of Vinyl Ethers 4z–4af
from Tertiary Alcohols: See Figure 4, Method C. Methyl propiolate
(2; 4.0 mmol) was added portionwise (in six portions, one portion
every 5 min) to a solution of 2-phenylbut-3-en-2-ol (3ad; 2.0 mmol)
and DABCO (0.20 mmol) in dry hexanes (5 mL). The reaction mix-
ture was stirred for 1 h or less (TLC control). The solvent was re-
moved under reduced pressure, and the residue was purified by
flash column chromatography (silica gel; n-hexane/EtOAc, 90:10)
to give 4ad (73%).
12.5 Hz, 1 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 20.6, 50.9,
79.6, 97.6, 117.1, 137.5, 161.3, 168.3 ppm. MS (70 eV): m/z (%) =
156 (5.6) [M]+, 127 (5.9), 102 (14), 84 (9.3), 71 (21), 55 (100).
HRMS: calcd. for C8H12O3 156.0786; found 156.0786.
Methyl (E)-3-({(8S,9S,10R,13R,14S,17R)-10,13-Dimethyl-17-[(R)-
6-methylhept-2-yl]-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradeca-
hydro-1H-cyclopenta[a]phenanthren-3-yl}oxy)acrylate (4p): 1H
NMR (400 MHz, CDCl3): δ = 0.67 (s, 3 H), 0.85 (d, 3JH,H = 6.6 Hz,
6 H), 0.91 (d, 3JH,H = 6.6 Hz, 3 H), 0.92–2.06 (m, 29 H), 2.31–2.42
Methyl (E)-3-(1-Ethynylcyclohexyloxy)acrylate (4z): 1H NMR
(m, 2 H), 3.68 (s, 3 H), 3.73–3.83 (m, 1 H), 5.25 (d, 3JH,H = 12.4 Hz, (400 MHz, CDCl3): δ = 1.28–1.35 (m, 1 H), 1.48–1.59 (m, 3 H),
1 H), 5.36–5.40 (m, 1 H), 7.54 (d, JH,H = 12.4 Hz, 1 H) ppm. 13C
NMR (100 MHz, CDCl3): δ = 11.9, 18.7, 19.3, 21.1, 22.6, 22.8,
1.62–1.74 (m, 4 H), 1.90–1.95 (m, 2 H), 2.65 (s, 1 H), 3.67 (s, 3 H),
3
5.38 (d, 3JH,H = 12.1 Hz, 1 H), 7.88 (d, 3JH,H = 12.1 Hz, 1 H) ppm.
23.8, 24.3, 28.0, 28.15, 28.21, 31.8, 31.9, 35.8, 36.2, 36.6, 36.9, 38.5, 13C NMR (100 MHz, CDCl3): δ = 22.3 (2 C), 24.7, 37.5 (2 C), 50.9,
39.5, 39.7, 42.3, 50.1, 51.0, 56.2, 56.7, 82.3, 97.0, 123.0, 139.3,
161.6, 168.5 ppm.
76.4, 78.2, 82.9, 99.5, 158.1, 168.2 ppm. MS (70 eV): m/z (%) = 208
(1.3) [M]+, 179 (2.8), 149 (7.4), 107 (56), 106 (35), 91 (61), 79 (100),
67 (44). HRMS: calcd. for C12H16O3 208.1099; found 208.1102.
Methyl (E)-3-(2-Oxo-1,2-diphenylethoxy)acrylate (4t): 1H NMR
3
(400 MHz, CDCl3): δ = 3.63 (s, 3 H), 5.33 (d, JH,H = 12.6 Hz, 1 Methyl (E)-3-(2-Methylbut-3-yn-2-yloxy)acrylate (4aa): 1H NMR
H), 6.21 (s, 1 H), 7.29–7.55 (m, 8 H), 7.63 (d, 3JH,H = 12.6 Hz, 1 H), (400 MHz, CDCl3): δ = 1.55 (s, 6 H), 2.61 (s, 1 H), 3.66 (s, 3 H),
7.92 (d, 3JH,H = 7.6 Hz, 2 H) ppm. 13C NMR (100 MHz, CDCl3): δ
5.35 (d, 3JH,H = 12.1 Hz, 1 H), 7.83 (d, 3JH,H = 12.1 Hz, 1 H) ppm.
13C NMR (100 MHz, CDCl3): δ = 29.1 (2 C), 50.9, 74.8, 75.0, 83.6,
= 51.2, 84.5, 99.0, 127.8 (2 C), 128.8 (2 C), 129.0 (2 C), 129.2 (2
C), 129.5, 133.7, 133.9, 134.1, 160.4, 167.6, 193.5 ppm. MS (70 eV): 99.7, 158.2, 168.0 ppm. MS (70 eV): m/z (%) = 168 (2.0) [M]+, 109
m/z (%) = 380 (1.4) [M]+, 195 (19), 191 (52), 167 (30), 165 (56), 131
(19), 105 (100), 77 (25). HRMS: calcd. for C18H16O4 296.1049;
found 296.1053.
(23), 71 (35), 67 (100), 65 (27). HRMS: calcd. for C9H12O3
168.0786; found 168.0783.
Methyl (E)-3-(2-Phenylbut-3-yn-2-yloxy)acrylate (4ab): 1H NMR
(400 MHz, CDCl3): δ = 1.86 (s, 3 H), 2.87 (s, 1 H), 3.63 (s, 3 H),
Methyl (S,E)-3-[(1-Methoxy-1-oxoprop-2-yl)oxy]acrylate (4u): [α]2D5
1
3
= –77.3 (c = 1.0, acetone). H NMR (400 MHz, CDCl3): δ = 1.52
5.43 (d, JH,H = 12.2 Hz, 1 H), 7.30–7.40 (m, 3 H), 7.52–7.55 (m,
3
3
(d, JH,H = 6.8 Hz, 3 H), 3.65 (s, 3 H), 3.75 (s, 3 H), 4.44–4.53 (m,
2 H), 7.60 (d, JH,H = 12.2 Hz, 1 H) ppm. 13C NMR (100 MHz,
3
3
1 H), 5.22 (d, JH,H = 12.6 Hz, 1 H), 7.46 (d, JH,H = 12.6 Hz, 1
CDCl3): δ = 32.2, 51.0, 77.4, 79.5, 82.4, 100.4, 125.8 (2 C), 128.6,
128.7 (2 C), 141.1, 158.8, 167.9 ppm. MS (70 eV): m/z (%) = 230
H) ppm. 13C NMR (100 MHz, CDCl3): δ = 17.8, 51.1, 52.5, 75.4,
98.2, 160.7, 167.6, 170.7 ppm. MS (70 eV): m/z (%) = 188 (17) (1.3) [M]+, 129 (100), 128 (45), 127 (18), 51 (13). HRMS: calcd. for
[M]+, 157 (41), 156 (40), 129 (80), 87 (54), 85 (43), 71 (52), 69 (29), C9H12O3 230.0943; found 230.0953.
59 (100). HRMS: calcd. for C8H12O5 188.0685; found 188.0685.
Methyl (E)-3-(1,3-Diphenylhept-1-yn-3-yloxy)acrylate (4ac): 1H
NMR (400 MHz, CDCl3): δ = 0.88 (t, JH,H = 7.2 Hz, 3 H), 1.28–
Methyl (E)-3-[(9H-Fluoren-9-yl)oxy]acrylate (4v): 1H NMR
3
3
(400 MHz, CDCl3): δ = 3.64 (s, 3 H), 5.47 (d, JH,H = 12.3 Hz, 1 1.35 (m, 3 H), 1.50–1.62 (m, 1 H), 1.99–2.06 (m, 1 H), 2.17–2.23
3
H), 5.94 (s, 1 H), 7.28–7.35 (m, 2 H), 7.40–7.47 (m, 3 H), 7.55 (d, (m, 1 H), 3.62 (s, 3 H), 5.47 (d, JH,H = 12.1 Hz, 1 H), 7.33–7.41
3JH,H = 7.5 Hz, 2 H),7.67 (d, 3JH,H = 7.5 Hz, 2 H) ppm. 13C NMR (m, 6 H), 7.53–7.57 (m, 4 H), 7.72 (d, JH,H = 12.1 Hz, 1 H) ppm.
3
(100 MHz, CDCl3): δ = 51.1, 82.7, 99.4, 120.3 (2 C), 125.5 (2 C), 13C NMR (100 MHz, CDCl3): δ = 13.9, 22.5, 26.7, 44.5, 50.9, 84.1,
128.1 (2 C), 130.0 (2 C), 140.9 (2 C), 141.1 (2 C), 160.8, 168.0 ppm. 86.9, 90.2, 100.0, 121.8, 126.4 (2 C), 128.40 (2 C), 128.43, 128.52
MS (70 eV): m/z (%) = 266 (1.2) [M]+, 166 (30), 165 (100), 163 (11),
(2 C), 129.1, 132.0 (2 C), 141.1, 159.4, 168.0 ppm. MS (70 eV): m/z
139 (5.1), 115 (2.9). HRMS: calcd. for C17H14O3 266.0943; found (%) = 348 (2.6) [M]+, 291 (100), 273 (25), 247 (53), 231 (17), 217
266.0942.
(29), 202 (34), 191 (35), 115 (25), 91 (34). HRMS: calcd. for
C23H24O3 348.1725; found 348.1713.
Methyl (E)-3-(Pent-4-yn-2-yloxy)acrylate (4w): 1H NMR
(400 MHz, CDCl3): δ = 1.38 (d, JH,H = 6.2 Hz, 3 H), 2.04 (s, 1 Methyl (E)-3-(2-Phenylbut-3-en-2-yloxy)acrylate (4ad): 1H NMR
3
H), 2.39–2.57 (m, 2 H), 3.68 (s, 3 H), 4.14–4.23 (m, 1 H), 5.26 (d, (400 MHz, CDCl3): δ = 1.74 (s, 3 H), 3.64 (s, 3 H), 5.33–5.38 (m,
3
3
3
3JH,H = 12.5 Hz, 1 H), 7.51 (d, JH,H = 12.5 Hz, 1 H) ppm. 13C
2 H), 5.46 (d, JH,H = 12.1 Hz, 1 H), 6.08 (dd, JH,H = 17.2 and
10.9 Hz, 1 H), 7.27–7.32 (m, 1 H), 7.33–7.39 (m, 4 H), 7.50 (d,
3JH,H = 12.1 Hz, 1 H) ppm. 13C NMR (100 MHz, CDCl3): δ =
26.1, 50.9, 84.6, 99.3, 116.6, 126.0 (2 C), 127.9, 128.5 (2 C), 140.6,
142.4, 158.7, 168.2 ppm. MS (70 eV): m/z (%) = 232 (7.1) [M]+, 131
(100), 129 (56), 118 (53), 115 (48), 105 (59), 91 (42), 77 (46).
HRMS: calcd. for C14H16O3 232.1099; found 232.1105.
NMR (100 MHz, CDCl3): δ = 19.3, 26.0, 51.1, 71.1, 77.2, 79.2,
97.6, 161.3, 168.2 ppm. MS (70 eV): m/z (%) = 167 (19) [M – 1]+,
139 (24), 137 (40), 129 (24), 124 (22), 109 (37), 103 (28), 102 (35),
71 (100), 67 (89), 66 (57), 65 (50). HRMS: calcd. for C9H11O3
167.0708; found 167.0705.
Methyl
(E)-3-({5-[(tert-Butyldimethylsilyl)oxy]pent-2-yl}oxy)-
acrylate (4x): H NMR (400 MHz, CDCl3): δ = 0.02 (s, 6 H), 0.87
(s, 9 H), 1.25 (d, JH,H = 6.2 Hz, 3 H), 1.45–1.71 (m, 4 H), 3.59 (t,
Methyl (E)-3-(1,1-Diphenylethoxy)acrylate (4ae): 1H NMR
(400 MHz, CDCl3): δ = 2.02 (s, 3 H), 3.62 (s, 3 H), 5.53 (d, JH,H
1
3
3
6
www.eurjoc.org
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 0000, 0–0